Lack of Association Between COMT Gene Polymorphism and Treatment Outcome in Major Depression

Basit Öğe Kaydı
dc.contributor.authorSelek, Salih
dc.contributor.authorKaya, Mehmet C.
dc.contributor.authorErdal, Mehmet Emin
dc.contributor.authorBulut, Mahmut
dc.contributor.authorOzen, Murat Eren
dc.contributor.authorYumru, Mehmet
dc.contributor.authorBarlas, Omer
dc.date.accessioned2024-04-24T17:49:55Z
dc.date.available2024-04-24T17:49:55Z
dc.date.issued2011
dc.departmentDicle Üniversitesien_US
dc.description.abstractBackground & Aim: Abnormal activity of Catechol-Omethyl transferase (COMT), as a major degrading enzyme of catecholaminergic neurotransmitters may be enrolled in the pathogenesis of mood disorders. The aim of this study was to investigate the association between COMT genetic polymorphism and major depression patients. Method: The study included 137 unrelated major depressive disorder (MDD) patients and 153 healthy unrelated controls, all were of Turkish origin. The patients were treated with antidepressant drugs for 8 weeks. All patients were assessed by Hamilton Depression Rating Scale (HDRS) before and after the antidepressant treatment. The analysis of COMT G1947A polymorphism was performed using PCR based endonuclease digestion method. Results: No significant difference was found between MDD and control subjects. In the MDD patients, there was no relationship between duration of illness, and pretreatment HDRS scores in respect to COMT gene polymorphism. The distribution of COMT genotypes and alleles was not significantly different among the controls and MDD patients. Conclusion: Our findings indicated that distribution of COMT genetic polymorphism were not different significantly between the patients and controls. No allele was found to be a predictor for treatment outcome by antidepressant therapy or for clinical manifestations in MDD.en_US
dc.identifier.endpage24en_US
dc.identifier.issn2146-1473
dc.identifier.issn2146-2380
dc.identifier.issue1en_US
dc.identifier.startpage19en_US
dc.identifier.urihttps://hdl.handle.net/11468/23091
dc.identifier.volume1en_US
dc.identifier.wosWOS:000218915800005
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.language.isoenen_US
dc.publisherYerkure Tanitim & Yayincilik Hizmetleri A Sen_US
dc.relation.ispartofJournal of Mood Disorders
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectComt Geneen_US
dc.subjectAntidepressant Treatment Responseen_US
dc.subjectGenderen_US
dc.subjectMajor Depressionen_US
dc.subjectPolymorphismen_US
dc.titleLack of Association Between COMT Gene Polymorphism and Treatment Outcome in Major Depressionen_US
dc.titleLack of Association Between COMT Gene Polymorphism and Treatment Outcome in Major Depression
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu